Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
Recruiting
Phase 4
Interventional Study
Burns
Skin Graft Complications
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 62 (estimated)
- Sponsor
- University of Kansas Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Investigators hypothesize that topical tranexamic acid will have better or comparable efficacy to topical thrombin in reducing hematoma formation at the wound base. The purpose of the study is to demonstrate that topical tranexamic acid will be a non-inferior alternative medication to the current standard of care,THROMBIN-JMI® , and at a lower cost to the health system.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* English or Spanish speaking
* Flame or scald burn injury
* \<=10% total body surface area (TBSA) partial thickness
* \<= 5% total body surface area (TBSA) deep partial or full thickness
* Skin graft harvested at 1/12 inch depth, meshed 1:1 or pie crusted if the area is a small…
Contacts